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involving splicing motifs in addition to the viral
Rem protein and RmRE
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Abstract
Background: Retroviral Gag proteins are encoded in introns and, because of this localization, they are subject to
the default pathways of pre-mRNA splicing. Retroviruses regulate splicing and translation through a variety of
intertwined mechanisms, including 5’- post-transcriptional control elements, 3’- constitutive transport elements, and
viral protein RNA interactions that couple unspliced and singly spliced mRNAs to transport machinery. Sequences
within the gag gene termed inhibitory or instability sequences also appear to affect viral mRNA stability and
translation, and the action of these sequences can be countered by silent mutation or the presence of RNA
interaction proteins like HIV-1 Rev. Here, we explored the requirements for mouse mammary tumor virus (MMTV)
Gag expression using a combination of in vivo and in vitro expression systems.
Results: We show that MMTV gag alleles are inhibited for translation despite possessing a functional open reading
frame (ORF). The block to expression was post-transcriptional and targeted the mRNA but was not a function of
mRNA transport or stability. Using bicistronic reporters, we show that inhibition of gag expression imparted a block
to both cap-dependent and cap-independent translation onto the mRNA. Direct introduction of in vitro
synthesized gag mRNA resulted in translation, implying a nuclear role in inhibition of expression. The inhibition of
expression was overcome by intact proviral expression or by flanking gag with splice sites combined with a
functional Rem-Rem response element (RmRE) interaction.
Conclusions: Expression of MMTV Gag requires nuclear interactions involving the viral Rem protein, its cognate
binding target the RmRE, and surprisingly, both a splice donor and acceptor sequence to achieve appropriate
signals for translation of the mRNA in the cytoplasm.
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Background
Eukaryotic mRNAs typically contain intronic sequences
that must be removed by ubiquitously acting splicing
mechanisms prior to nuclear export. Splicing occurs co-
transcriptionally and affects pre-mRNA stability, 5’ and
3’ end formation, nuclear export, cytoplasmic trafficking
and stability, as well as translation [1,2]. As the pre-
mRNA emerges from PolII it is complexed with a very
dynamic series of proteins that forms the mRNP (mes-
senger ribonucleoprotein). Components of the mRNP
and changes to those components regulate nuclear and
cytoplasmic steps in mRNA metabolism [1-4].
Post-integration, retroviruses largely utilize host tran-
scription and translation mechanisms to proceed
through the replication cycle. Retroviruses initiate a
complex transcription profile that is driven by alterna-
tive splicing and results in three distinct RNA species:
unspliced genome-length transcripts, singly spliced tran-
scripts, and fully spliced transcripts. For all retroviruses,
the primary structural protein Gag is encoded by an
intron in the unspliced genomic RNA. Thus, Gag trans-
lation requires unique mechanisms to overcome the
default eukaryotic splicing pathway and transport an
intron-containing mRNP to the cytoplasm.
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In parallel with the evolving complexity of their
expression programs, retroviruses have acquired increas-
ingly complex mechanisms to regulate mRNA proces-
sing and export. One of these strategies is the adoption
of suboptimal splice sites and splicing enhancers and
suppressors that regulate the capacity of cellular
machinery to cleave the mRNA prior to export [5-8].
This strategy is adopted by the avian sarcoma leukosis
viruses (ASLV), murine leukemia virus (MLV), and
other simple retroviruses, but it is also maintained in
more complex retroviral species. In addition to subopti-
mal splicing, some betaretroviruses contain intronic
RNA structures, called constitutive transport elements
(CTE), which directly bridge the interaction of singly-
spliced and genomic mRNAs with proteins of the TAP
transport pathway [9]. Complex retroviruses add an
additional level of control by encoding a regulator of
RNA export from a spliced viral mRNA and utilizing a
different export pathway. These proteins, the prototype
of which is human immunodeficiency virus type 1
(HIV-1) Rev, interact with an RNA structural element in
underspliced gag or env mRNAs and couple them to the
Crm1 export pathway [10-15].
MMTV has been extensively studied as a model for
breast cancer. Much emphasis has been given to defin-
ing the hormonal regulation of transcription and the
mechanisms of cellular transformation [16,17]. MMTV
encodes a regulatory protein Rem [13,18] that is func-
tionally equivalent to HIV Rev. Rem interacts with
unspliced or singly-spliced RNA through a secondary
structure, the Rem response element (RmRE), that spans
the 3’ end of the env gene and part of the 3’long term-
inal repeat (LTR) [14,19]. This interaction is required
for transport of genome-length RNA from the nucleus
to the cytoplasm through Crm1 [13,18].
Although initially identified due to their role in trans-
port of unspliced viral RNA from the nucleus to the
cytoplasm, regulatory proteins like Rev have been shown
to possess other functions. Both HIV-1 Rev and Jaag-
siekte sheep retrovirus (JSRV) Rej enhance gag transla-
tion [15,20]. HIV-1 Rev accomplishes this by increasing
the stability of gag-containing mRNA in the cytoplasm
[21] and by enhancing the association of RRE-containing
mRNAs with polysomes [20,22]. The mechanism of
translational enhancement by JSRV Rej has not been
thoroughly characterized, but is clearly independent of
mRNA export [15]. The stability of HIV-1 unspliced
mRNAs is regulated by inhibitory or instability
sequences (INS) present in introns, including the gag
ORF. These elements function in the absence of other
viral genes or proteins and render the RNA unstable in
the cytoplasm such that the presence of INS can result
in reduced translation [21]. The RNA instability can be
overcome by silent mutagenesis of the INS or by
addition of Rev in trans [23]. Similarly, Butsch et al.
have demonstrated that, despite efficient RNA export to
the cytoplasm, gag-containing constructs fail to translate
unless 5’-UTR elements, termed post-transcriptional
control elements (PCE) interact with RNA helicase A
[24-27]. These data further support the existence of
inhibitory sequences within the gag ORF.
Relatively little is known about the basic virus-host
interactions leading to MMTV expression, assembly and
replication in contrast to the current understanding of
MLV-, or HIV-1-host interactions. This lack of knowl-
edge fundamentally results from an inability to bacte-
rially propagate MMTV proviral genomes or subviral
constructs containing intact gag genes derived from exo-
genous virus but not those from germline-encoded ele-
ments. The gag genes from endogenous murine viruses
propagate in plasmid vectors; therefore, the two avail-
able MMTV infectious molecular clones pHyb-Mtv [28]
and pGR102 [29] contain the gag gene from germline-
encoded Mtv1 and Mtv8, respectively. They differ in the
remainder of the viral genome. The sequence that
impedes bacterial propagation of MMTV is localized in
the pp21 domain of gag and has been termed the “bac-
terial poison sequence” [30]. An exogenous, GR strain
gag gene, containing a 57-nucleotide deletion in the
pp21 domain, efficiently propagated in bacteria, suggest-
ing that the deleted region encompassed the bacterial
poison sequence. Zabransky et al. silently mutated all
the possible nucleotides in the sequence targeted by the
deletion creating a Gag-only expression construct SM
(silently mutated) that readily propagated as a bacterial
plasmid and expressed Gag in eukaryotic cells [31].
However, SM Gag failed to assemble into virus-like
particles or into detectable subviral structures in vitro,
or in cells (unpublished data). Since the gag gene in the
pHyb-Mtv infectious molecular clone (Mtv-1) makes
infectious progeny upon SM Gag expression, it is clear
that this gag allele is expression and assembly compe-
tent. Nevertheless, when Mtv-1 gag was introduced into
the same expression construct used to successfully
express SM Gag, no protein was expressed. Similar
results were obtained from a highly homologous, puta-
tive human-origin, MMTV gag, HBRV (human betare-
trovirus) in the same expression system. In contrast, all
three gag genes expressed equivalently in cell-free,
coupled, transcription-translation reactions.
We show that transcript abundance, nuclear-cytoplas-
mic transport, and transcript stability were equivalent
among the inhibited Mtv-1 and HBRV alleles as well as
Gag-producing SM allele. Our results suggest that inhi-
bition of gag expression is a nuclear event that manifests
its phenotype in the cytoplasm through translational
inhibition. Interestingly, rescue of the phenotype
requires the presence of the RmRE, and for gag to be in
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an intron flanked by splice donor and acceptor sites.
Therefore, the history of the mRNA in the nucleus
imparts an inhibitory phenotype that can be overcome
by Rem and splicing motifs. Our results suggest contri-
butions of splicing motifs and machinery and RNA
export signals in the ‘licensing’ of the MMTV gag-con-
taining mRNAs for translation.
Results
The silently-mutated gag expresses protein from a
heterologous promoter, but wild-type Gag expression is
undetectable
Three gag alleles were cloned into a cytomegalovirus
(CMV) immediate-early promoter vector (pcDNA3.1)
that has a bovine growth hormone polyadenylation sig-
nal (Figure 1A). The ORFs were introduced to place the
gag ATG initiation codon into a consensus Kozak
sequence, and all constructs were verified by DNA
sequencing. The Mtv-1 gag was selected because it is
plasmid-propagatable and because an infectious molecu-
lar clone (pHyb-Mtv) containing this allele exists. A
putative human origin MMTV gag allele, (HBRV), that
is 99.7% identical to Mtv-1 at the nucleic acid and
amino acid levels, was also included. The third allele,
SM, was derived from the MMTV GR strain, but was
previously silently mutated [31] in the gag pp21 domain
to eliminate the bacterial poison sequence. Despite dis-
crete points of polymorphic sequence, HBRV and Mtv-1
gag do not phylogenetically segregate from one another,
but both segregate from MMTV GR, the source of the
SM gag allele. The level of nucleic acid identity between
HBRV/Mtv-1 and SM gag is 92.7%, whereas the amino
acid identity is 95.9%. The highest disparity between
HBRV/Mtv-1 and SM lies within the silently mutated
gag pp21 region. The alterations in SM result in an
increase in the overall G/C content in this region from
31.5% to 51.9%, yet none of the three gag genes
appeared more codon optimized than another as indi-
cated by their codon adaptation indices (Mtv-1 = 0.137,
HBRV = 0.138, SM = 0.151, compared to an optima of
0.958) [32].
Gag expression constructs were transfected into HEK
293T cells and subjected to metabolic labelling followed
by immunoprecipitation with a rabbit polyclonal anti-
MMTV CA antibody. Little or no Mtv-1 Gag or HBRV
Gag was detected when expressed from CMV-based
gag-only constructs; however, SM Gag was readily
detected. Moreover, Mtv-1 Gag derived from the pSMt-
Hyb provirus was also expressed to detectable levels
(Figure 1B). Quantification of the levels of pulse-labeled
Gag derived from the CMV vectors revealed an approxi-
mately 95-fold inhibition of these two constructs relative
to SM Gag (p < 0.05). Expression of another MMTV
Gag (Mtv-8) from the same vector was similarly
restricted (data not shown). Given that Mtv-1 gag and
the gag from the pSMt-Hyb provirus are identical, these
results indicated the presence of a repression acting
against Mtv-1 Gag ORF expression as well as a virus-
mediated derepression that allows Mtv-1 Gag expression
from the provirus.
Since human cells are not predicted to be the natural
host for MMTV replication, barriers to MMTV expres-
sion could be responsible for the inhibition of Gag
expression observed. A similar inhibition has been
reported in efforts to express HIV-1 Gag in murine cells
[33]. Therefore, we tested whether Gag expression con-
structs produced protein in C57BL6 murine embryonic
fibroblast (MEF) cells. We were surprised to find that
both Mtv-1 and HBRV failed to express Gag whereas
the pSMt-Hyb infectious molecular clone and the SM
Gag variant expressed at high levels (Figure 1C, SM and
pSMt-Hyb lanes). MMTV is clearly capable of replica-
tion in murine cells, and the virus is readily produced
by transfection of infectious molecular clones into
human cells [34-36]. Our data suggest a blockade to
translation of Gag expressed in the absence of the rest
of the genome in murine cells, and these data are sup-
ported by earlier reports from Vaidya et al., although
the cause for this lack of expression was not determined
[37].
Gag expression was also tested in two human breast
cancer cell lines MCF7 and T47D and in African green
monkey kidney (COS-1) cells. Similar to our data for
Gag expression in HEK 293T and MEF cells, little or no
HBRV or Mtv-1Gag was detected, but SM Gag expres-
sion was evident in all cell lines tested (Additional File
1).
All gag alleles express in vitro
Given the perplexing lack of protein expression in the
CMV-gag transfection experiments, we sought to verify
construct integrity and the sensitivity and capability of
our polyclonal antibody to detect proteins derived from
the various gag alleles. We took advantage of the fact
that pcDNA3.1 vectors contain a phage T7 RNA poly-
merase promoter that can be used to express RNA in
vitro. The in vitro synthesized RNA was then used to
program in vitro rabbit reticulocyte lysate translation
reactions that included [35S]-methionine. The resulting
labelled protein was separated by SDS-PAGE and either
visualized directly by autoradiography, or subjected to
immunoblotting. All Gag constructs expressed similar
levels of protein in reticulocyte lysates (Figure 1D),
demonstrating that all three mRNAs are competent for
programming transcription and translation in vitro. We
verified these bands were indeed Gag since the product
of each construct was equivalently detected by immuno-
blotting with polyclonal anti-MMTV CA antibody
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Figure 1 Gag constructs produce protein in vitro but not in mammalian cells. A) Schematic representation of the three gag expression
constructs: Mtv-1 gag, HBRV gag and SM gag. CMV = human cytomegalovirus immediate early promoter; ORF = open reading frame; BGH polyA
= bovine growth hormone polyadenylation site. B) HEK 293T cells and C) MEF cells were transfected with the indicated gag plasmids. Gag
protein production was assayed 24 hr post-transfection by metabolic labeling with35S methionine (1 hr pulse) followed by immunoprecipitation
with rabbit polyclonal anti-MMTV CA sera and an antibody to b-catenin to control for cellular equivalents. Pr77gag, Gag precursor (77 KDa) and b-
catenin (98 KDa) are indicated. D) The three gag constructs were transcribed and translated in vitro in a rabbit reticulocyte lysate. A T7 promoter-
driven b-galactosidase gene that produces a 110 KDa product was included as a system control (+C). E) Western immunoblot of in vitro
translated Gag with MMTV anti-CA sera. In this case, the b-galactosidase reaction serves as a negative control for the antibody (-C).
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(Figure 1E). These results demonstrate that there is
neither differential detection nor differential translation
capacity between constructs. Taken together, these
results support the concept of specific inhibition of
expression of Gag dependent upon the allele present in
the construct.
Expression timing and protein stability do not account
for lack of Gag protein
Since all three gag-only constructs have the same pro-
moter and would be anticipated to express with similar
kinetics, we determined the expression of each at 24, 48
and 72 hrs post-transfection by pulse labeling. SM Gag
was detectable, but Mtv-1 and HBRV Gag expression
was inhibited at all time points (Figure 2A). We also
assessed steady-state Gag levels by immunoblotting.
Only the SM Gag was detected 48 and 72 hrs post-
transfection (Figure 2B). One explanation for the above
results might be that Mtv-1 and HBRV Gag are highly
labile proteins and therefore do not accumulate. To test
this concept, we subjected CMV-gag transfected cells to
metabolic pulse-labeling for 15 minutes with no chase.
This time-frame was anticipated to catch synthesized
protein before it could be degraded. Under these condi-
tions, we did not detect either Mtv-1 or HBRV Gag. A
robust SM Gag band was evident (Figure 2C). We also
used the proteasomal inhibitor MG132 (Figure 2D) or
lactacystin (not shown) to block protein degradation
and turnover. Proteasomal inhibition was demonstrated
by a treatment-induced increase in GFP as well as
A)
HBRV                                  
48 hr 72 hr
Pr 77gag
D)
a b c a b c a b c a b c
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Figure 2 Lack of Gag expression is not a function of timing or protein stability. A) 293T cells were transfected with the indicated gag
constructs and (24, 48 or 72 hrs post-transfection) were metabolically labelled for 1 hr followed by IP with the MMTV anti-CA antibody and a
control antibody to b-catenin. Pr77gag, Gag precursor. (77 KDa) and b-catenin (98 KDa). B) Steady-state levels of Gag in HEK 293T cells at 48 and
72 hrs after transfection were detected by using immunoprecipitation followed by Western blot. Triplicate transfections (a, b, c) are shown, Mo =
Mock transfected cells. Pr77gag, the Gag precursor (77 KDa). C) HEK 293T cells were transfected with the indicated plasmids or mock transfected.
Twenty-four hours post-transfection, the cells were subjected to a 15-min pulse followed by lysis and immunoprecipitating with the MMTV anti-
CA antibody. Pr77gag, Gag precursor. D) HEK 293T cells were transfected with the indicated gag constructs or gfp and treated 24 hr later with
the proteasome inhibitor MG132 for 2 hr. Gag and GFP levels were quantified by radiolabeling and immunoprecipitating with an MMTV anti-CA
antibody or with an anti-GFP antibody. Lower panel shows quantification of the Gag and GFP levels in the presence or absence of the
proteasome inhibitor. Data are average of three independent experiments ± SD. “+” = MG132-treated cells, “-” = DMSO-treated cells, DLU =
digital light units. Pr77gag, the Gag precursor (77 KDa), b-catenin (98 KDa), and GFP (27 KDa).
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increased b-catenin signal at 98 KDa. We also noted the
presence of higher molecular weight bands in the pre-
sence of the proteasomal inhibitor that likely represent
accumulation of ubiquitinated and polyubiquitinated b-
catenin (Figure 2D). These higher weight forms of b-
catenin are also present in the GFP-only lane, and there-
fore, are not Gag. Despite evidence of proteasome inhi-
bition, no Mtv-1 or HBRV Gag was detected in treated
cell lysates. SM levels, however, increased in response to
treatment, indicating that a substantial proportion of
Gag fails to assemble, and is degraded intracellularly
(Figure 2D), as has been demonstrated in other retro-
viral systems [38]. Thus our results show that Mtv-1
and HBRV gag constructs fail to undergo protein synth-
esis rather than producing a labile gene product,
whereas the SM gag construct is not subject to a similar
constraint.
Gag transcripts are efficiently synthesized in human cells
Our data suggest that the lack of detectable Gag results
from a lack of Gag protein synthesis and not from pro-
tein degradation or instability. Therefore, the block in
protein expression could result from three potential
defects: the lack of gag mRNA, the lack of gag mRNA
transport to the cytoplasm, or the inability to translate
the Gag transcript if synthesized and appropriately
transported. To identify the defect, we tested for corre-
lations between gag mRNA levels and protein expression
between constructs. Real-time PCR (qRT-PCR) was used
to quantify transcript abundance, nuclear to cytoplasmic
transport, and mRNA stability. We primed cDNA synth-
esis in transfected cells from an oligo-dT primer and
performed Taqman detection using an amplicon over
conserved sequences in pp21. The amplification signal
(Ct) for gag mRNA from the respective constructs was
normalized to that of cellular gapdh and the reciprocal
ratios were compared. We observed no significant differ-
ence in mRNA abundance for the different gag alleles
(Figure 3A), indicating that all gag transcripts were pre-
sent at the same level and that the lack of Gag expres-
sion was not a function of mRNA abundance.
Nuclear to cytoplasmic transport and mRNA stability are
similar for all gag alleles
We next asked whether the various gag mRNAs can
traffic from the nucleus to the cytoplasm. Subcellular
fractionation was used to extract mRNA from nuclear
and cytoplasmic fractions, and the abundance of the gag
transcript in each fraction was quantified relative to
gapdh by using qRT-PCR. To control for proper nuclear
and cytoplasmic separation, we assessed the distribution
of histone 3 and GAPDH proteins in the different frac-
tions. We found that histone 3 was present only in the
nuclear fraction while GAPDH was only in the
cytoplasm (data not shown). All gag mRNAs were
detected in the cytoplasmic fraction, and quantification
of the ratio of the nuclear-to-cytoplasmic transcript
abundance revealed no difference between gag con-
structs; therefore, the transport of all gag mRNAs was
equivalent (Figure 3B). This result suggests that Mtv-1
and HBRV Gag expression was not impaired by a defect
in mRNA transport.
Inhibited translation of HIV-1 gag has been linked to
cytoplasmic instability of the RNA imparted by instabil-
ity (INS) sequences in Gag [21,39]. To determine
whether the various gag mRNAs displayed differential
stability in the cytoplasm, CMV-gag transfected cells
were treated with the transcription inhibitor actinomy-
cin D. The gag mRNA abundance was quantified rela-
tive to gapdh by using qRT-PCR at 2, 4, and 6 hr after
treatment. No differences in mRNA stability were
detected among Mtv-1, HBRV and SM over the 6 hr
treatment course (Figure 3C).
Since we determined that analyses of RNA synthesis,
transport and stability do not affect the differential pro-
tein expression phenotypes evinced between SM and the
two other MMTV gag alleles, we conclude that the
A) B)
C)
Figure 3 Inhibition of expression occurs post-transcriptionally
and does not affect mRNA transport and stability. A) Total RNA
was extracted from HEK 293T cells transfected with Mtv-1, HBRV,
and SM gag constructs. The gag and gapdh mRNAs were reverse
transcribed into cDNA using an Oligo-dT primer and quantified by
Real-Time PCR. The relative abundance of gag mRNA to gapdh is
calculated as the reverse of the ratio of gag CT to gapdh CT value.
B) Transfected HEK 293T cells were separated into nuclear and
cytoplasmic fractions. The mRNA was extracted from each fraction,
and gag and gapdh mRNAs were quantified by reverse transcription
Real-Time PCR. The level of mRNA transport from the nucleus to the
cytoplasm was quantified as the ratio of nuclear and cytoplasmic
gag mRNA relative to gapdh. C) Cells were treated with actinomycin
D, and RNA was extracted from the cells at 0, 2, 4 and 6 hrs post-
treatment and quantified by reverse transcription Real-Time PCR.
The relative abundance of gag mRNA to gapdh was calculated at
each time point. Data are the average of at least three independent
experiments ± SD.
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block to Gag expression occurred post-transcriptionally
such that the mRNA is not translatable although it was
transported to the cytoplasm.
Negative regulation against Mtv-1 and HBRV gag acts at
the transcript level
Post-transcriptional inhibition of Gag expression could
function in two ways: (1) the inhibition directly targets
the transcript for sequestration or degradation similar to
that which occurs in RNAi pathways or (2) Mtv-1 and
HBRV gag transcripts fail to support translation initia-
tion. In the latter, this would be envisioned as a failure
to successfully recruit or engage translation factors
essential for cap-dependent translational initiation. To
differentiate between these mechanisms, we introduced
gag alleles into a bicistronic plasmid vector in which the
Gag translation is driven by cap-dependent initiation
and eGFP is translated from an encephalomyocarditis
virus- internal ribosome entry site (EMCV-IRES) (Figure
4A). We reasoned that if inhibition was at the level of
gag translation initiation, then no Gag would be pro-
duced from cap-dependent initiation; but the production
of eGFP from the cap-independent IRES would proceed
unabated. However, if the inhibition acts to prevent all
interactions of the mRNA with translational machinery,
then neither cistron would be expressed.
Bicistronic constructs were transfected into HEK293T
cells and the transfected cultures were observed by in
situ fluorescent microscopy for eGFP expression prior
to lysis and immunoprecipitation to quantify MMTV
Gag expression. In a parallel analysis, we used qRT-PCR
to demonstrate that all bicistronic constructs trans-
ported mRNA to the cytoplasm (data not shown). We
observed no eGFP signal from the bicistronic construct
containing HBRV gag, and immunoprecipitation
revealed no detectable Gag from the first cistron of this
construct (Figure 4B and 4C). In contrast, for the SM










Figure 4 Negative regulation against Mtv-1 and HBRV gag acts at the transcript level. A) The gag ORF was cloned in the multiple cloning
site of pIRES-eGFP upstream of the IRES and GFP, and was under the control of the CMV promoter. B) Expression of GFP was visualized by
fluorescence microscopy. The “empty” pIRES-eGFP construct was used as a control for GFP expression. C) Gag levels were quantified by pulse
labeling and immunoprecipitation with an MMTV anti-CA antibody. Pr77gag, the Gag precursor (77 KDa).
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produced (Figure 4B and 4C). Since both constructs
contained the same Kozak sequence and IRES, the inhi-
bition resulted from recognition of sequences within gag
and not from a defect in translational initiation. Thus,
gag sequences appear to either inhibit translational
‘licensing’ of the mRNA or to completely sequester the
mRNA away from translational machinery.
Inhibition is dependent on the nuclear history of the
mRNA
Analysis of bicistronic constructs suggested that the gag
mRNA was not competent for translation (Figure 4), yet
all three gag mRNAs can program a rabbit reticulocyte
lysate to make protein (Figure 1D). We, therefore, tested
whether in vitro synthesized gag RNAs were competent
to program translation if delivered directly to cells by
transfection. This approach was also reasoned to provide
some capacity to distinguish between cytoplasmic or
nuclear mechanisms of translational inhibition. The
pcDNA3.1 constructs contain a T7 RNA polymerase
promoter that was used to drive RNA synthesis in vitro.
A portion of each in vitro synthesized gag RNA was
used to program a rabbit reticulocyte lysate to test RNA
integrity and the remainder of the same preparation was
introduced into HEK293T cells using lipid mediated
transfection. In contrast to transfection of plasmid
pCDNA3.1 gagconstructs (Figure 5A and 5C), the in
vitro synthesized gag RNAs (derived from the same con-
struct) were fully competent to program translation in
the RNA transfected cells (Figure 5B and 5D). While we
do not formally know whether the introduced RNA
remained cytoplasmic or trafficked to the nucleus, these
results suggest that inhibition of Mtv-1 and HBRV Gag
translation was imposed in the nucleus or acts co-
transcriptionally.
Rescue of Gag expression by the RmRE and Rem in trans
is dependent on splice recognition sites
Expression of MMTV gag from a proviral construct is
readily detected while the same reading frame is inhib-
ited in a gag-only construct. This suggests an inhibition
targeting gag ORF and a viral mechanism to overcome
it. We have shown that this inhibition targets the
mRNA in the nucleus and prevents its translation in the
cytoplasm. From studies using other retroviruses, there
are two potential viral mechanisms that rescue Gag
expression from inhibition. The first, as exemplified by
spleen necrosis virus and Mason-Pfizer monkey virus,
involves an interaction between cellular RNA helicase A
and the viral 5’ UTR that enhanced viral mRNA associa-
tion with ribosomes [24,25]. The second is post-tran-
scriptional enhancement of HIV-1 translation by the
viral Rev protein [40].
The MMTV LTR and 5’UTR sequences are not sufficient to
rescue Gag expression
The natural promoter for MMTV Gag is in the 5’LTR
and requires glucocorticoid stimulation for activity [41].
While expression from the LTR is typically lower than
from CMV promoter-driven over-expression systems,
testing whether addition of glucocorticoid (dexametha-
sone) rescued expression was deemed worthwhile.
Moreover, given reports that the presence of an authen-
tic 5’ UTR can be important for regulating retroviral
expression [42], and that the 5’-UTR can enhance trans-
lation of the gag gene [25], we created an MMTV gag
construct driven by its own LTR. We deleted pol and
part of the env gene from pHyb-Mtv while maintaining
the 3’LTR. The resultant construct, pLTR-gag (Figure
7A), contains the 5’ and 3’ LTRs, Mtv-1 gag, pro, the
RmRE and sag. Gag expression from this construct was
reduced compared with that from the intact provirus
(Additional File 2). This result suggests that having all
of the known 5’ cis-sequences, the RmRE and the 3’
LTR from the provirus fails to support expression of
Gag at levels similar to an intact proviral construct con-
taining the same gag ORF. Moreover, addition of dexa-
methasone had no impact on Gag expression except
from the intact provirus. Thus the 5’-UTR appears to be
insufficient to rescue Gag expression.
Rem and RmRE are insufficient to rescue CMV-driven Gag
expression
The gag expression constructs presented thus far do not




HBRVMtv-1 SM Mock HBRVMtv-1 SM Mock
A) B)
D)C)
Figure 5 Inhibition is dependent on the nuclear history of the
mRNA. A) Plasmid or B) in vitro made mRNA for the indicated
constructs was transfected into HEK 293T cells. After 24 hr, Gag
expression was quantified by pulse labeling for 1 hr and
immunoprecipitating with an MMTV anti-CA antibody. b-catenin
immunoprecipitation served as a loading control. Gag expression
from plasmid C) or in vitro made mRNA D) was quantified relative
to b-catenin. Data represent the average of three experiments ± SD.
Pr77gag, the Gag precursor (77 KDa) and b-catenin (98 KDa).
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anticipated to be independent of the RNA transport-
mediated activities of Rem. Our data quantifying nuclear
and cytoplasmic gag mRNA levels support this concept.
However, several reports have suggested post-transcrip-
tional roles for Rev and its analogs that potentially
impact Gag protein expression [15,21]. These data
prompted us to test whether the observed restriction
against Gag expression results from the lack of Rem or
the lack of a Rem/RmRE interaction.
We began by verifying the functionality of three pre-
viously published Rem constructs (Rem-only, GFP-Rem,
and GFP-RemSP) [13] by testing their capacity to med-
iate expression of an intronic Renilla luciferase reporter
from pHMRluc, a construct that also contained the
RmRE (Additional File 3). We tested whether providing
Rem in trans altered expression from the CMV-gag only
constructs lacking a RmRE (not shown) and observed
no effect. Thus, the silent alterations in SM gag did not
introduce a Rem responsive cis-element. Next, we
cloned the RmRE sequence (nt 7291-7886) into the 3’
UTR of the CMV-driven gag constructs (Figure 6A). For
a precise location of the RmRE sequence compared to
the Mtv-1 genome and relative to the published RmRE
see Additional File 4. After verifying that no extraneous
mutations were introduced in gag, we demonstrated that
the construct expression profiles remained unchanged
from those observed in the absence of the RmRE (Figure
6B compare lanes ‘1’ to Figure 1B). However, co-
gag ORF
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D) E)
Figure 6 Rem in trans along with RmRE rescues Gag expression from an artificial intron. A) Schematic representation of the gag
constructs that contain the RmRE. First the RmRE was introduced in the 3’UTR of pcDNA3.1 gag construct, downstream of the gag stop codon,
but upstream of the polyA site (CRmRE). In a second construct gag was inserted between the second splice donor and splice acceptor from the
MMTV infectious molecular clone, and upstream of the RmRE and the viral 3’LTR (CssRmRE). Mtv-1, HBRV, and SM gags from the CRmRE B) and
CssRmRE C) were expressed in HEK 293T cells in the presence or absence of Rem. Lanes indicate 1, GFP; 2, Rem; 3, GFP-Rem; 4, GFP-RemSP; +,
GFP-Rem; -, GFP co-transfections. Gag expression was assayed 24 hrs post-transfection by radiolabeling and immunoprecipitating with MMTV
anti-CA and anti-b-catenin antibodies. Rem expression in the same samples CRmRE D) and CssRmRE E) is shown by Western blot with a rabbit
polyclonal anti-GFP antibody. Pr77gag, Gag precursor (77 KDa), b-catenin (98 KDa), GFP-RemSP (40 KDa) and GFP (27 KDa). Gag levels from
CRmRE F) and CssRmRE G) were quantified relative to b-catenin ± SD in the presence and absence of different Rem constructs. Lanes indicate 1,
GFP; 2, Rem; 3, GFP-Rem; 4, GFP-RemSP; +, GFP-Rem; -, GFP. Data are average of three independent transfections.
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transfection of Rem did not rescue Gag expression
despite the presence of the RmRE (Figure 6B and 6F;
lanes 2, 3, and 4). In Figure 6D, anti-GFP immunoblot-
ting was utilized to demonstrate expression of the two
Rem fusion constructs provided in trans. Moreover, no
difference in the levels of cytoplasmic mRNA between
gags expressed in the presence or absence of Rem was
detected. This result suggested that providing Rem in
trans did not alter nuclear-to-cytoplasmic transport of
these gag mRNAs despite the presence of its cognate
RmRE cis sequence.
Rem in trans along with RmRE rescues Gag expression from
an artificial intron
When expressed from the viral LTR, both the genome
length gag/gag-pro-pol mRNA and the subgenomic, sin-
gly-spliced env mRNA are contained within introns. Yet
the cellular default is to completely splice pre-mRNA
before transport to the cytoplasm. Like other complex
retroviruses, MMTV encodes a trans-acting, Rev-like
regulatory protein, Rem, which in combination with the
RmRE, is necessary for expression of intronic viral gene
products [13,18]. We replaced Renilla luciferase in
pHMRluc gene with the three gag genes. In this context,
gag is in the intron and should not be expressed unless
splicing is overcome by a transport regulator. As antici-
pated, no Gag expression was detected from this con-
struct in the absence of Rem (Figure 6C and 6G ‘-’
lanes). However, with Rem in trans, equivalent Gag
expression was evident for all three constructs (Figure
6C and 6G’+’ lanes). Figure 6E shows immunoblots of
the GFP-Rem fusion proteins and controls. Results from
these investigations demonstrate that Rem can rescue
Gag expression but only when gag is flanked by a splice
donor and acceptor, and the mRNA contains the
RemRE.
Rem along with the RmRE and natural splice donor and
acceptor sequences rescues Gag expression
Based on the results demonstrating Gag expression from
an artificial intron RmRE construct, we revisited the
MMTV pLTR-gag construct where Rem failed to rescue
Gag expression despite the fact that pLTR-gag contained
an intact RmRE (Figure 7B and 7F and Additional File
4). As in Figure 6, immunoblotting for GFP was utilized
to demonstrate expression of the GFP-Rem fusion pro-
tein (Figure 7D and 7E). Although the major splice
donor was present in pLTR-gag, both viral splice accep-
tors had been deleted (Figure 7A). Upon reconstruction
of the splice acceptor into the pLTR-gag construct
(pLTR-gagSA), Rem was able to rescue Gag expression
(Figure 7C and 7G and Additional File 4). This result
further supports the concept that Rem requires, in addi-
tion to the RmRE, the recruitment of splicing machinery
to gag intron splice donor and acceptor sites, yet such
recruitment does not result in cleavage of the intron.
This complex of cis and trans factors is necessary to
support MMTV Gag translation.
Discussion
Nuclear protein-mRNA interactions impact viral RNA
transport. The transport mechanisms (Crm1 or Tap/
NXT), in turn, influence the localization and fate of the
viral mRNA or gRNA in the cytoplasm. These relation-
ships are evident from studies of RSV in which deletion
of a direct repeat upstream of src that functions as a
CTE leads to efficient Gag production but lack of parti-
cle assembly [43,44]. Similar defects are observed in
attempts to express ALV in mammalian cells [45-47],
but the defect can be overcome by driving ALV through
the Crm1 RNA export pathway by providing an HIV-1
RRE and Rev in trans [48]. HIV-1 Gag expression can
be achieved in murine cells, but processing, viral RNA
encapsidation, and particle formation are not supported
unless the HIV-1 RNA is exported via a CTE export
pathway [33]. Murine expression of HIV-1 Gag can be
achieved in a Rev/RRE/Crm1-dependent pathway but
only if human SRp40 and SRp55 are provided ectopi-
cally [49]. In addition, post-transcriptional control ele-
ments (PCE) in the 5’ UTR of a number of retroviruses
have been shown to interact with nuclear or cytoplasmic
RNA helicase A to promote mRNP remodeling that
facilitates polyribosome association resulting in efficient
translation [26,42]. Thus protein marks applied to the
pre-mRNA in the nucleus, in addition to defining the
RNA export pathway, contribute to localization and fate
of the RNA in the cytoplasm.
From the studies mentioned above, as well as from
our CMV-gag expression data (Figure 1), it is clear that
mRNA export alone is insufficient to stimulate transla-
tion of retroviral Gag. All alleles of MMTV gag that
were tested with the CMV promoter were efficiently
exported, presumably by a Tap/NXT pathway, yet differ-
ential Gag translation occurred among the alleles. We
propose that RNA ‘fate’ determinants are being applied
to MMTV gag mRNAs that are dependent upon
sequences within the ORF. These RNA fate decisions
are potent enough to prevent cap-independent transla-
tion of reporters in the second position of bicistronic
constructs, suggesting that nuclear ‘marks’ applied to
the mRNA and direct its cytoplasmic localization such
that it is sequestered from all translation machinery.
Yet, the RNA is not degraded.
Rev controls the transition between early and late
phases of HIV-1 replication by regulating the export of
incompletely spliced viral mRNA to the cytoplasm.
While promoting unspliced mRNA export is regarded as
its primary function, Rev has also been shown to affect
the stability, translation and encapsidation of RRE-con-
taining RNAs [40,50]. Rev has been shown to overcome
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inhibitory or instability (INS) sequences present in the
gag ORF [21] by preventing cytoplasmic RNA degrada-
tion. The gag RNA can also be protected from degrada-
tion and efficiently expressed if it is codon optimized or
if the INS sequences are mutated [39]. The fact that
silent mutations in MMTV SM gag overcome inhibition
of expression acting against Mtv-1 suggests that wild-
type MMTV gag genes may contain an INS. However,
in contrast to the HIV-1 inhibitory sequences, which
trigger the viral RNA for degradation, all MMTV gag
mRNAs were stable in the cytoplasm whether translated
or not. Moreover, our analyses of the three MMTV gag
alleles did not reveal evidence of codon optimization, or
lack thereof, by any particular gag. Thus, we concluded
that MMTV gag sequences were subject to post-tran-
scriptional control mechanisms, but they function
differently from the mRNA degradation pathways that
act against HIV-1 gag. HIV-1 INS sequences were
bound in the nucleus by PSF, a transcription/splicing
factor, which in turn affected the fate of the RNA in the
cytoplasm [51]. It remains to be tested whether a similar
interaction dictates the fate of the MMTV gag alleles.
Like HIV-1, MMTV has been characterized as a com-
plex retrovirus due to the presence of the Rev analog,
Rem, that temporally controls MMTV gene expression
[13]. Rem has been shown to interact with a structured
element in unspliced and singly-spliced mRNAs [14]
and to promote transport of these RNAs to the cyto-
plasm [13,18]. Mertz et al. demonstrate that Rem
enhances translation of an intronic reporter without
affecting RNA transport [52]. Moreover, Hofacre et al.

















































Figure 7 Rem, the RmRE and natural splice donor and acceptor sequences rescue Gag expression. A) Schematic representation of the
MMTV infectious molecular clone (pHyb-Mtv) and the two subviral clones created (LTRgag and LTR+SA). LTR, long terminal repeat; SD, splice
donor; SA, splice acceptor, RmRE, Rem response element. gag, pro, pol, env, sag are the viral genes. Expression of Gag from pLTRgag B) or pLTR
+SA C) was assayed in 293T cells by pulse labeling and immunoprecipitating with an MMTV anti-CA antibody in the presence or absence of
GFP-Rem. Transfection of pHyb-Mtv served as a positive control. ‘-’ lanes were transfected with GFP to equilibrate the plasmid load. b-catenin
was used as a cellular control. Expression of GFP and GFP-Rem was visualized by immunoblotting with an anti-GFP antibody in pLTRgag D) or
pLTR+SA E) transfected cells. Pr77gag, the Gag precursor (77 KDa), b-catenin (98 KDa), GFP-Rem (66 KDa), GFP-RemSP (40 KDa) and GFP (27 KDa).
Gag levels from the LTRgag F) and LTR+SA G) were quantified relative to b-catenin. Data are average of three independent transfections ± SD.
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involved in cytoplasmic enhancement of translation not
in nuclear-to-cytoplasmic RNA transport [15]. In our
hands, gag bicistronic constructs were efficiently trans-
ported to the cytoplasm. If cap-dependent translation
was inhibited by the gag allele in the first cistron, no
reporter was expressed by cap-independent translation
from the second cistron. Thus, the RNA has been tar-
geted by an inhibition that manifests as a total and irre-
versible block to translation. This inhibition is likely a
function of RNA localization as opposed to failure to
initiate translation since IRES-mediated translation is
also inhibited. These results reinforce the concept that it
is the gag sequence itself that is the target of inhibition
since the eGFP reporter is efficiently co-expressed when
SM Gag is expressed. Moreover, direct RNA transfec-
tions reveal that the inhibition is nuclear in origin since
all gag alleles were equally competent to program trans-
lation. These allele-specific effects on Gag translation
are summarized in Figure 8. We reasoned that the
directly transfected RNA either does not have access to
the nucleus or it escapes a binding partner that is co-
transcriptionally acquired. While our data are consistent
with that of others demonstrating a phenotypic transla-
tional block, we show that this blockade is actually
imposed as a nuclear mark on the RNA.
The nucleotide sequences among complex retroviruses
are not highly conserved. It is therefore not surprising
that there is little consensus in RNA regulatory mechan-
isms other than a requirement for a cis regulatory ele-
ment (like the RmRE) and a cognate trans-RNA-binding
factor (like Rem). Other sequences in the RNA may be
essential because of their capacity to specifically coordi-
nate nuclear proteins. In the elucidation of Rem and Rej
function, reporter constructs that contain splice sites
have been used to assay effects on RNA transport
[13,15]. However, in the absence of Rem and Rej the
intron-containing constructs were exported, but not
expressed. The interpretation was that the function of
Rem and Rej was to enable translation rather than RNA
transport. The potential role of the splice sites and their
capacity to coordinate nuclear proteins that impact
mRNA fate was not directly addressed. We have shown
that the presence of splice sites, but not their utilization,
is required in addition to the RmRE and Rem for Gag
expression. This is potentially due to interaction of
these sequences with protein partners as has been
shown in HIV-1 where U1 snRNP interaction with the
5’ splice site is required for Rev function [53]. However,
we show that the 5’ MMTV splice site alone is insuffi-
cient to support efficient export and translation. Simi-
larly, any combination other than a functional splice
donor and acceptor with a functional Rem and RmRE
interaction is insufficient. Figure 8 shows our conceptual
model of Gag translation competence. Retroviral RNAs
have been demonstrated to interact with a variety of
proteins that are constituents of RNA splicing transport
and localization complexes, including hnRNPA1, hnRNP
A2, I/PTB, DDX1, DDX3, RHA, nucleolin, Sam68, ASF/
SF2, SRp40/p55, EF1a, Pur1a, and Staufen [54-56]. We
conclude that MMTV Gag expression requires splicing
sites on the mRNA in addition to viral RNA regulatory
components. Yet while these interactions are essential to
facilitate the cytoplasmic expression of Gag, they do not
function normally since the intron is not removed. It is
possible that Rem is participating in direct and perhaps
inhibitory interactions with splicing components that
are important for transport or RNA localization and uti-
lization or perhaps the virus has adapted to subvert
nuclear RNA-binding protein function in order to
achieve its expression program. Thus, it is clear that in
the presence of a complete set of viral cis signals as well
as the viral Rem protein, MMTV gag RNA is exported
through Crm1 [13], and through these signals, allele-
specific inhibitory mechanisms are countered making
gag competent for translation. Our findings suggest that
continued investigation of the proteins that differentially
interact with Mtv-1 and SM gag alleles may enlighten
our understanding of how nuclear mRNP interactions
participate in regulating RNA localization and fate.
Conclusions
Nuclear interactions inhibit MMTV gag gene expression
independent of RNA transport, stability, and translation.
To overcome the inhibition and achieve translation of
MMTV gag mRNA in the cytoplasm, both the Rem pro-
tein and its cognate binding target the RmRE, and sur-
prisingly, a splice donor and acceptor sequence are
required.
Methods
Cell culture and transfections
Human embryonic kidney (HEK 293T) cells, and murine
embryonic fibroblasts (MEF) were maintained in Dul-
becco’s Modified Eagle Medium supplemented with 10%
fetal bovine serum, L-glutamine (20 mM), penicillin
(100 U/mL) and streptomycin (100 μg/mL). Cells were
grown to 60-80% confluency in 60 mm plates and were
transfected with 5 μg of the indicated plasmid DNA at a
1:3 ratio of DNA to FuGene 6 (Roche), following the
manufacturer’s instructions and were assayed 24 hr
post-transfection, or as indicated.
Plasmid constructs
All restriction enzymes were purchased from New Eng-
land Biolabs, and Pfu polymerase was acquired from
Stratagene. The hybrid MMTV provirus (pHyb-Mtv)
(graciously provided by Jackie Dudley Ph.D.) [28] and
pSMt-HYB [57], which is an MMTV infectious
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molecular clone driven by the Mason-Pfizer monkey
virus LTR were used as positive controls. The gag
sequences utilized as templates for amplification, muta-
genesis and expression were Mtv-1 (accession #
AF228550), MMTV GR [58-60] and HBRV [61].
Sequences encoding the Gag ORF were PCR amplified
using primers: Forward: 5’-ACCATGGGGGTCTCGG-3’
and Reverse: 5’- TTACAAGTTTTTTGAATTTTCGG-
3’. For HBRV gag, the template DNA was amplified by
PCR ‘stitching’ of three patient-derived template frag-
ments,: 174-1 (accession # AF513918), 175-3 (accession
# AF513919) and 168-2 (accession # AF513914) [61].
The pHyb-Mtv plasmid was used as a source for Mtv-1
gag and the silently-mutated (SM) MMTV GR gag from
the pDAB-MMTV plasmid, which allows plasmid propa-
gation [31], was the source for SM gag. Amplified pro-
ducts were TA-cloned into pCR2.1 TOPO (Invitrogen)
and then transferred into the eukaryotic expression vec-
tor pcDNA3.1 (Invitrogen) by EcoRI restriction digestion
and ligation. The orientation of the gene in pcDNA3.1
was determined by StuI restriction digestion, and cor-
rectly oriented clones were sequenced across the reading






































Figure 8 Schematic representation of gag mRNAs and their translation phenotypes. Full length viral mRNA is capped (7MeG) and
polyadenylated (An), as are all other constructs. At the 5’ and 3’ ends of the viral genome length RNA, the R and U5 or U3 elements are
indicated as grey (R) blue (U5) and purple boxes (U3). The viral open reading frames (ORF) gag, pol, and env are indicated while other genes are
not presented to maintain clarity. The splice donors (SD) and splice acceptors (SA) are represented as green or orange triangles, respectively. The
viral protein Rem (blue half moon) is shown bound to its cis RNA structural element, the RmRE. Three subviral mRNAs, derived from various CMV
promoter constructs, are also depicted. The minimal expression construct contains only the cap, gag ORF, and poly-A tail. Also depicted is the
mRNA from a gag bicistronic construct that contains an IRES element supporting cap-independent translation of eGFP. The second subviral
construct includes the RmRE, to which Rem (provided in trans) is shown to bind. The third subviral gag expression construct contains both a SD
and SA positioning the gag ORF in an intron as well as the RmRE and Rem in trans. Expression of Gag protein from the different mRNAs is
indicated as a purple polypeptide exiting the ribosome (red). For subviral constructs, loss of protein expression as a result of the included gag
allele is indicated by dotted lines and by the absence of Gag polypeptide exiting the ribosome. Similarly, when the bicistronic constructs fail to
support Gag expression, the lack of GFP production from the IRES is indicated by the dotted line and lack of the green polypeptide exiting the
ribosome. The lightning bolt represents direct transfection of gag mRNAs where allele-independent Gag translation was detected.
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The RmRE sequence [14,19] was PCR amplified with
the primers: Forward: 5’-TTTGATATCCATTGTTTTC-
CAGTGCCTTGC-3’ and Reverse: 5’-TTTCTCGAGCT
CTTTCTATTTTCTATTCCCATTTC-3’ and intro-
duced into the EcoRV and XhoI sites of the pcDNA gag
constructs. The plasmids pHMRluc, Rem, RemGFP and
RemSPGFP were a gift from Dr Jackie Dudley [13]. To
introduce the gag ORFs in the pHMRluc construct,
Renilla luciferase was excised by PCR, and the XmnI
site reconstituted. The three gag ORFs were introduced
by digestion and blunt ligation from pcDNA3.1
constructs.
pLTR-gag was derived from pHyb-Mtv by excision of
the sequence present between the two BglII sites. To
introduce the splice acceptor (SA) site back into the
pLTR-gag, the sequence spanning the SA (nt 6993-7384)
was PCR amplified from pHyb-Mtv using primers that
contain the BglII site (Forward: 5’- AGGAGATCTG-
CAAATTATGATTTTATCTGCG- 3’ Reverse: 5’- CG
GCATTTCCCCCTTTTTTC-3’). After PCR, the
sequence was introduced into pLTR-gag by restriction
digestion and ligation. To create bicistronic constructs
the three gags were cloned in the multiple cloning site
(EcoRI) of pIRES2-EGFP (Clonetech).
Immunoprecipitation and Western blot
Cells were washed 3 times with PBS and labeled for 1 hr
with35S Cys/Met trans-label (MP biomedicals) at 100
μCi/mL in Cys/Met-free medium. Immunoprecipitations
were performed as described [62]. Briefly, cells were
lysed in Lysis Buffer A (0.15 M NaCl, 50 mM Tris-HCl
(pH 7.5), 1% Triton X-100 and 1% deoxycholate), the
nuclei were removed by centrifugation at 14,000 × g for
1 min, after which SDS was added to 0.1% final concen-
tration. Gag proteins were precipitated with 3 μL rabbit
polyclonal anti-MMTV CA antibody and 25 μL forma-
lin-fixed Staphylococcus aureus. Immunoprecipitated
proteins were separated on 10% SDS-PAGE followed by
quantitative phosphorimager analysis. To normalize for
quantification, we immunoprecipitated in parallel with
an anti-b-catenin antibody (AC-15) (Sigma). The same
anti-MMTV CA antibody was used for Western blots.
To detect Rem-GFP fusions and GFP we used a rabbit
polyclonal anti-GFP antibody (Sigma).
In vitro transcription and translation
To synthesize proteins in vitro we used the STP3 kit
(Novagen) following the manufacturer’s instructions. To
program mRNA synthesis, 500 μg of plasmid containing
the T7 promoter (pcDNA3.1 Gag or controls) was intro-
duced into a T7 polymerase transcription mixture. The
reticulocyte lysate was added to the transcription reac-
tion to translate protein in the presence of35S-
Methionine. A b-galactosidase plasmid provided with
the kit was used as a positive control.
Protein stability
HEK 293T cells were transfected as described. After 24
hours the cells were pulsed for 15 minutes with 100
μCi35S trans label, and the proteins were immunopreci-
pitated and analyzed by Western blotting with the anti-
MMTV CA antibody.
Twenty-four hours after transfection, parallel cultures
of HEK293T cells were treated with 20 μM MG132
(Sigma) or an equivalent volume of DMSO for 2 hours
to block proteasomal degradation. Concomitantly, cells
were metabolically labelled with 100 μCi/mL35S Cys/
Met trans-label (MP biomedicals) in Cys/Met-free med-
ium. After two hours of treatment and labelling, protein
accumulation was quantified as described previously.
RNA quantification
RNA was extracted using Trizol reagent (Invitrogen) fol-
lowing the manufacturer’s instructions. Carry-over DNA
was digested with TurboDNase (Ambion) 1 hr at 37°C.
For cDNA production, 5 μg of RNA were used to tem-
plate SuperScript III reverse transcription (Invitrogen).
RNA abundance was quantified by real-time PCR using
Taqman technology on an ABI 7500 Fast Real-time PCR
System. Briefly, 20 μL reaction volumes contained 10 μL
of 2× Reaction Mixture (Ambion), 1 μL primer and
probe mix, 2 μL of the template cDNA and 7 μL water.
Standard thermal cycling and data collection parameters
were utilized. Amplification of gag cDNA was normal-
ized to gapdh. Gag primers were forward: 5’-TGAA-
GAAAAGGAGAAGGCA GA-3’, and reverse: 5’-
CTCAGGGGACAGGTCATCAT-3’ and the probe was
5’-Fam-AAGGCCTTTTTA GCCACAGATTGG-Tamra-
3’ and GAPDH primers were primer forward: 5’-
GAAGGTGAAGGTCGGAGTC-3’, and reverse: 5’-
GAAGATGGTGATGGGATTTC-3’ and probe was 5’-
JOE-CAAGCTTCCCGTTCTCAGCC-Tamra -3’.
Nuclear-cytoplasmic extracts
HEK 293T cells were partitioned into nuclear and cyto-
plasmic fractions using a Cell Fractionation Buffer
(PARIS kit, Ambion). RNA was extracted and quantified
as described above. mRNA transport was measured as
the nuclear to cytoplasmic gag mRNA ratio relative to
gapdh as measured by using qRT-PCR of cDNA.
RNA stability
Transcription was blocked by addition of 5 μg/mL acti-
nomycin D. RNA was extracted at 0, 2, 4 and 6 hr after
treatment and quantified by using qRT-PCR as
described above. The relative transcript abundance at
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each time point was calculated as the ratio of gag CT to
gapdh CT.
Fluorescence microscopy
To visualize eGFP expressed from the bicistronic con-
structs, in transfected HEK 293T cells we used an
Olympus IX70 microscope with a DP70 camera at a
magnification of 20×.
In vitro synthesized mRNA
To make capped mRNA in vitro we used the mMessage
mMachine system (Ambion) following manufacturer’s
instructions. The mRNA was first verified in vitro to sup-
port translation. Equivalent amounts of mRNA were then
transfected into 293T cells using Lipofectamine 2000
(Invitrogen). Gag expression was assayed as described
above by pulse labeling and immunoprecipitation.
Additional methods
The human breast cancer cell lines T47D and MCF7
were grown in RPMI-1640 Medium and Eagle’s Mini-
mum Essential Medium, respectively, and supplemented
with 10% fetal bovine serum, L glutamine (20 mM),
penicillin (100 U/mL), streptomycin (100 μg/mL) and
0.01 mg/mL bovine insulin. COS-1 cells were grown in
DMEM.
Luciferase assay
Cells were seeded at 5 × 104 per well in 24-well plates,
then transfected with 2 μg of the appropriate plasmid
DNA using Fugene 6 (Roche) at 1:3 DNA:Fugene ratio.
Twenty-four hrs after transfection, the cell lysates were
assayed for luciferase activity using the Renilla Lucifer-
ase Assay System (Promega) following manufacturers
instructions. Luminescence was integrated over 1 sec-
ond with a 2-second delay on a PerkinElmer 1420
Multilabel Counter Victor3V. Each transfection was
done in triplicate and each lysate was assayed in
triplicate.
Additional material
Additional file 1: (PPT) Similar Gag expression profiles are seen in
several cell types. The indicated gag constructs were transfected into
COS-1 cells, and the human breast carcinoma cell lines, T47D and MCF7.
After 24 hr Gag expression was assayed by metabolic labeling followed
by immunoprecipitating with anti-MMTV CA antibody. +C, pSMt-HYB.
Pr77gag, the Gag precursor (77 KDa) is indicated by the arrow.
Additional file 2: (PPT) The cognate 5’ UTR does not rescue Gag
expression. MMTV Gag was expressed in HEK 293T cells either from an
intact provirus (pHyb-Mtv) or from the MMTV pLTR-gag construct in the
presence or absence of dexamethasone (Dex). After 24 hrs,
dexamethasone was added to the cells and 48 hrs post transfection, cells
were radiolabeled and Gag expression was assayed by
immunoprecipitating with anti-MMTV CA antibody. Pr77gag, the Gag
precursor (77 KDa).
Additional file 3: (PPT) Rem enhances expression of a reporter
gene. To verify Rem function, we used the reporter plasmid pHMRluc in
which Renilla luciferase is in an intron, upstream of the Rem response
element. pHMRluc was cotransfected with the indicated plasmids and
luciferase activity was integrated over one second. The average of
triplicate luciferase readings of three independent transfections ± SD is
shown. A plasmid expressing Renilla luciferase from a CMV promoter was
used as a positive control (Renilla) and mock-transfected cells were used
as a negative control. The GFP lane shows the basal luciferase expression
from the pHMRluc plasmid.
Additional file 4: (PPT) Location of RmRE elements in constructs.
The viral genomic RNA from nt 6709-8564 in Mtv-1 (see Methods for
accession #) is shown on the top line with the splice acceptor 2 (SA2)
indicated by the orange triangle and the initiation and termination
codons of Sag and Env. The two published RmRE sequences are
depicted relative to their position versus the reference genome.
Following the published RmRE sequences are those utilize in the current
manuscript beginning with the sequence that was introduced into the
CMV promoter Gag-only constructs (CRmRE) and the same construct
containing splice donor and acceptor sequences (CssRmRE). The final
two sequences are those that were introduced into proviral derived Gag
expression constructs that lacked the splice acceptor (LTRgag) or
contained a functional splice acceptor (LTR+SA). For clarity, promoter and
gag sequences 5’ to the area introduced to contain the RmRE and splice
sites are not shown.
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